Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailInsuffisance rénale et vitamine D
Krzesinski, Jean-Marie ULg

Learning material (2009)

Detailed reference viewed: 17 (2 ULg)
See detailL'insuffisance rénale
Krzesinski, Jean-Marie ULg

Conference given outside the academic context (2009)

Detailed reference viewed: 22 (6 ULg)
See detailL'insuffisance rénale
Krzesinski, Jean-Marie ULg

Conference (2010, May 30)

Detailed reference viewed: 10 (2 ULg)
Peer Reviewed
See detailInsuffisance rénale, syndrome inflammatoire et anévrysme de l'aorte abdominale ... où est le lien?
Vazquez, C.; Bonnet, Pierre ULg; Fastre, M. et al

in Revue Médicale de Liège (1997), 52(8), 511-4

Detailed reference viewed: 39 (0 ULg)
See detailInsuffisance respiratoire et isocinétisme
Croisier, Jean-Louis ULg; Georis, Pierre ULg; Hac, S. et al

in Isocinétisme et personnes âgées (2000)

Detailed reference viewed: 34 (2 ULg)
See detailInsuffisance respiratoire postopératoire - sevrage
Sottiaux, T.; Damas, Pierre ULg

in Anesthésie Réanimation Chirurgicale (1990)

Detailed reference viewed: 28 (3 ULg)
See detailL'insuffisance surrénale isolée: Une cause inhabituelle d'hypoglycémie du nourrisson
Mascart, F.; Pieltain, Catherine ULg; Andoura, B. et al

in Journées annuelles de la Société Belge de Pédiatrie (1991)

Detailed reference viewed: 23 (0 ULg)
See detailinsuffisance throïdienne transitoire du nouveau-né: épidémiologie et clinique
Battisti, Oreste ULg; Gérard, P.; Bachy, A.

Conference (1982)

Detailed reference viewed: 9 (1 ULg)
Peer Reviewed
See detailLes insuffisances mitrales ischémiques: principes de leur traitement chirurgical
RADERMECKER, Marc ULg; Limet, Raymond ULg

in Revue Médicale de Liège (1995), 50(7), 295-7

L'insuffisance mitrale ischémique est une manifestation peu fréquente de la maladie cotanarienne. Elle constitue par ailleurs une entité relativement mal connue. Il peut s'agir de complications aiguës ou ... [more ▼]

L'insuffisance mitrale ischémique est une manifestation peu fréquente de la maladie cotanarienne. Elle constitue par ailleurs une entité relativement mal connue. Il peut s'agir de complications aiguës ou chroniques de la maladie ischémique. Leur compréhension est facilité par la classification fonctionnelle de Carpentier. A l'occasion de cette revue, nous précisons les indications elles modalités de traitement de ce type d'insuffisance mitrale. [less ▲]

Detailed reference viewed: 19 (0 ULg)
Full Text
See detailInsula quae in mari nascitur occupantis fit: nullius enim esse creditur!
Gerkens, Jean-François ULg

in Cascione, Cosimo; Masi Doria, Carla (Eds.) Fides Humanitas Ius. Studi in onore di Luigi Labruna (2007)

This text deals with the problem of an vulcanic island in the Mediterranean. The approach is to try to solve the diplomatic issue with roman law rules.

Detailed reference viewed: 37 (1 ULg)
Full Text
Peer Reviewed
See detailInsulae quae in mari nascitur occupantis fit: nullius enim esse creditur! Le cas de Ferdinandea vu par un romaniste
Gerkens, Jean-François ULg

in Fides, Humanitas, Ius, Studii in onore di Luigi Labruna (2007)

Detailed reference viewed: 13 (1 ULg)
Full Text
Peer Reviewed
See detailL'insularisation comme mode de transition, le cas de l'agriculture de conservation en Région Wallonne
Vankeerberghen, Audrey ULg; Dannevoye, Bastien ULg; Stassart, Pierre M ULg

in de Raymond, Antoine; Goulet, Frédéric (Eds.) Sociologie des grandes cultures, au coeur du modèle industriel agricole (2014)

Bien que peu connue du grand public, l'agriculture de conservation est un modèle qui se développe aujourd'hui dans les systèmes de grandes cultures de nombreux pays et qui gagne peu à peu la ... [more ▼]

Bien que peu connue du grand public, l'agriculture de conservation est un modèle qui se développe aujourd'hui dans les systèmes de grandes cultures de nombreux pays et qui gagne peu à peu la reconnaissance d'institutions publiques . L'agriculture de conservation vise à un meilleur respect de la vie du sol à travers trois principes : la réduction du travail du sol (techniques sans labour), la couverture permanente des sols et des rotations de cultures adaptées. En Europe, l’agriculture de conservation a connu un intérêt croissant à partir du milieu des années 1990. En Région wallonne (Belgique) les surfaces en non-labour représenteraient 15-20% de l’assolement en céréales d’hiver et moins de 10% pour les autres cultures (Greenotec 2012). Ce chapitre adresse la question des modalités de transition des agriculteurs wallons vers ce mode de production. Pour traiter cette problématique, nous nous appuyons sur les acquis des « Sustainability Transition Studies » (Markard 2012) afin d'analyser les modalités d'articulation entre l'agriculture de conservation et le système agricole dominant. L'articulation de la théorie multi-niveaux développée par Geels (2002) avec le concept d'innovation par retrait (Goulet et Vinck 2012) nous amènera à développer l'hypothèse de l'insularisation pour caractériser le processus de transition vers l'agriculture de conservation. La particularité de ce processus d'insularisation est que celui-ci s'effectue à travers une dynamique à la fois de détachement et de continuité avec l'agriculture dite conventionnelle. L'analyse de trajectoires d'agriculteurs présentée ici permettra d'identifier ces modalités de détachement et de continuité. Elle nous mènera également à questionner le cadre théorique proposé par Geels (2002) ainsi que la notion d'agriculture conventionnelle en elle-même. [less ▲]

Detailed reference viewed: 167 (29 ULg)
Peer Reviewed
See detailInsulin action in man.
Scheen, André ULg; Lefebvre, Pierre ULg

in Diabètes & Métabolism (1996), 22(2), 105-10

Insulin action is crucial for the regulation of glucose metabolism. Insulin plays a key role in suppressing endogenous glucose production by the liver, both in fasting and postprandial states. Insulin is ... [more ▼]

Insulin action is crucial for the regulation of glucose metabolism. Insulin plays a key role in suppressing endogenous glucose production by the liver, both in fasting and postprandial states. Insulin is also necessary for the maintenance of normal rates of glucose oxidation and storage in insulin-sensitive tissues and for the prevention of excessive gluconeogenic substrate production. Various methods have been developed to assess insulin action in vivo, essentially at liver and muscle sites. Such methods evaluate the effect of exogenous or endogenous insulin, using respectively the open-loop approach (interruption of the feedback loop by inhibiting endogenous insulin secretion) or the closed-loop approach (mathematical modelling of the insulin-glucose feedback loop). Knowledge of the successive steps of cellular insulin action has markedly improved during the last ten years. Preceptor, receptor and postreceptor levels need to be considered since they may be affected in insulin-resistant states. This general progress in the understanding of insulin action in man improves our approach to the complex pathophysiology of non-insulin-dependent diabetes mellitus and opens up new prospects for treatment of the insulin-resistant syndrome which is associated with several atherosclerotic risk factors. [less ▲]

Detailed reference viewed: 14 (0 ULg)
Peer Reviewed
See detailInsulin and metabolic abnormalities in children and family history of NIDDM. The Belgian Luxembourg Child Study.
Guillaume, Michèle ULg; Lapidus, L.; Beckers, F. et al

in International Diabetes Epidemiology Group, Official Satellite Symposium of the 15th IDF Congress (1994)

Detailed reference viewed: 4 (1 ULg)
Full Text
Peer Reviewed
See detailInsulin clearance during hyper-insulinemia euglycemia therapy
Penning, Sophie ULg; MASSION, Paul ULg; Pretty, Christopher ULg et al

in Proceedings of the 11th Belgian Day on Biomedical Engineering (2012, December)

Detailed reference viewed: 32 (13 ULg)
Full Text
Peer Reviewed
See detailInsulin clearance during hyper-insulinemia euglycemia therapy
Penning, Sophie ULg; MASSION, Paul ULg; Pretty, Christopher ULg et al

Poster (2012, December)

Detailed reference viewed: 35 (14 ULg)
Full Text
Peer Reviewed
See detailInsulin Detemir in the Treatment of Type 1 and Type 2 Diabetes
Philips, J. C.; Scheen, André ULg

in Vascular Health and Risk Management (2006), 2(3), 277-83

Insulin detemir is a soluble long-acting human insulin analogue at neutral pH with a unique mechanism of action. Following subcutaneous injection, insulin detemir binds to albumin via fatty acid chain ... [more ▼]

Insulin detemir is a soluble long-acting human insulin analogue at neutral pH with a unique mechanism of action. Following subcutaneous injection, insulin detemir binds to albumin via fatty acid chain, thereby providing slow absorption and a prolonged metabolic effect. Insulin detemir has a less variable pharmacokinetic profile than insulin suspension isophane or insulin ultralente. The use of insulin detemir can reduce the risk of hypoglycemia (especially nocturnal hypoglycemia) in type 1 and type 2 diabetic patients. However, overall glycemic control, as assessed by glycated hemoglobin, is only marginally and not significantly improved compared with usual insulin therapy. The weight gain commonly associated with insulin therapy is rather limited when insulin detemir is used. In our experience, this new insulin analogue is preferably administrated at bedtime but can be proposed twice a day (in the morning and either before the dinner or at bedtime). Detemir is a promising option for basal insulin therapy in type 1 or type 2 diabetic patients. [less ▲]

Detailed reference viewed: 48 (0 ULg)
Peer Reviewed
See detailInsulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery.
Paolisso, G.; Sgambato, S.; Varricchio, M. et al

in European Journal of Medicine (The) (1992), 1(5), 261-7

OBJECTIVES: This study aimed at investigating the effects of pulsatile and continuous insulin delivery on glucose kinetics in non-insulin-dependent (type 2) diabetic patients with secondary failure to ... [more ▼]

OBJECTIVES: This study aimed at investigating the effects of pulsatile and continuous insulin delivery on glucose kinetics in non-insulin-dependent (type 2) diabetic patients with secondary failure to oral hypoglycaemic agents. METHODS: Seven type 2 diabetic patients underwent a 585 minute glucose-controlled glucose intravenous infusion using the Biostator. The endogenous pancreas secretion was inhibited by somatostatin. Three experiments were performed in each patient on different days and in random order. In all cases, glucagon was replaced (58 ng/min). The amounts of insulin infused were: a) 0.15 mU/kg x min continuously; b) 0.20 mU/kg x min continuously and c) 1.0 mU/kg x min in 2 minute pulses every 13 minutes. D-[3-3H]-glucose infusion allowed determination of glucose kinetics. RESULTS: Infusion of identical amounts of insulin (A vs C) demonstrated that pulsatile insulin delivery exerted greater metabolic effects (higher glucose infusion rate and, mainly at the beginning of the experiment, lower endogenous glucose production) than continuous infusion; furthermore pulsatile insulin delivery (C) exerted metabolic effects similar to those of a greater dose of insulin (B) infused continuously. CONCLUSIONS: In type 2 diabetic patients with secondary failure to oral hypoglycaemic agents, pulsatile insulin delivery exerts greater metabolic effects than continuous hormone delivery. [less ▲]

Detailed reference viewed: 7 (0 ULg)
Peer Reviewed
See detailInsulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1.
Peers, Bernard ULg; Sharma, S.; Teitelman, G. et al

in Molecular Endocrinology (1994), 8(12), 1798-806

The development of endocrine cell types within the pancreas is thought to involve the progressive restriction of pluripotential stem cells, which gives rise to the four major cell types: insulin ... [more ▼]

The development of endocrine cell types within the pancreas is thought to involve the progressive restriction of pluripotential stem cells, which gives rise to the four major cell types: insulin-, glucagon-, somatostatin-, and pancreatic polypeptide-expressing cells. The mechanism by which these peptide hormone genes are induced and then either maintained or repressed during development is unknown, but their coexpression in early precursor cells suggests the involvement of common regulatory factors. Here we show that the somatostatin transcription factor STF-1 is also a principal regulator of insulin expression in beta-cells of the pancreas. STF-1 stimulates the insulin gene by recognizing two well defined islet-specifying elements on the insulin promoter and by subsequently synergizing in trans with the juxtaposed helix-loop-helix protein E47. Within the STF-1 protein, an N-terminal trans-activation domain functions cooperatively with E47 to stimulate insulin transcription. As truncated STF-1 polypeptides lacking the N-terminal activation domain strongly inhibit insulin promoter activity in beta-islet cells, our results suggest that the specification of islet cell types during development may be in part determined by the expression of STF-1 relative to other islet cell factors. [less ▲]

Detailed reference viewed: 23 (0 ULg)